Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Response of refractory osteosarcoma to thalidomide and celecoxib.

× No keyword cloud information.

7 in total

1. Phase II study of doxorubicin and thalidomide in patients with refractory aggressive fibromatosis.

Authors: Xin Liu; Huijie Wang; Xianghua Wu; Xiaonan Hong; Zhiguo Luo
Journal: Invest New Drugs Date: 2017-11-23 Impact factor: 3.850

Review 2. Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors: Ingrid Lilienthal; Nikolas Herold
Journal: Int J Mol Sci Date: 2020-09-19 Impact factor: 5.923

3. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma.

Authors: Ren Chen; Xiaohai Li; Bin He; Wei Hu
Journal: Mol Med Rep Date: 2017-01-26 Impact factor: 2.952

4. Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma.

Authors: Yi He; Haiting Zhou; Wei Wang; Haoran Xu; Hao Cheng
Journal: Front Genet Date: 2021-05-17 Impact factor: 4.599

5. Lenalidomide, celecoxib, and azacitidine therapy for blastic plasmocytoid dendritic cell neoplasm: a case report.

Authors: Marta Garcia-Recio; Jordi Martinez-Serra; Leyre Bento; Rafael Ramos; Jordi Gines; Jaime Daumal; Antonia Sampol; Antonio Gutierrez
Journal: Onco Targets Ther Date: 2016-09-07 Impact factor: 4.147

Review 6. Antiangiogenic therapy for primitive neuroectodermal tumor with thalidomide: A case report and review of literature.

Authors: Qing Li; Yong Liu; Yang Yu
Journal: Medicine (Baltimore) Date: 2017-12 Impact factor: 1.817

7. Complete response associated with lenalidomide and celecoxib in a case of primary refractory Hodgkin lymphoma.

Authors: Marta Garcia-Recio; Jordi Martinez-Serra; Francesc Mestre; Leyre Bento; Jordi Gines; Rafael Ramos; Jaime Daumal; Paloma López; Antonia Sampol; Antonio Gutierrez
Journal: Onco Targets Ther Date: 2018-10-08 Impact factor: 4.147

7 in total